HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE

Clinical trials for HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE explained in plain language.

Never miss a new study

Get alerted when new HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE trials appear

Sign up with your email to follow new studies for HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug aims to tame dangerous mineral in kidney patients

Disease control Completed

This study tested a new drug called AP301 to see if it works as well as or better than a standard medication (sevelamer) at controlling high phosphorus levels in the blood of people on long-term dialysis. It involved 474 Chinese adults with chronic kidney disease who were receivi…

Matched conditions: HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE

Phase: PHASE3 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE

Get alerted when new HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE trials appear

New drug aims to tame dangerous mineral in kidney patients